Back to search

Article

Emerging Protein Targets in Triple Negative Breast Cancer: Beyond Conventional Therapy

2026-01-13

Abstract excerpt

Triple-negative breast cancer (TNBC) remains one of the most aggressive and therapeutically challenging breast cancer subtypes, lacking expression of estrogen receptor, progesterone receptor, and HER2. Conventional chemotherapy and immune check-point inhibitors provide some benefit, but resistance and relapse are frequent. The search for novel targets has therefore become central to developing more effective and d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
af683491-619f-5d31-9543-239dbeb05a5c
DOI
10.20944/preprints202601.0915.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Emerging Protein Targets in Triple Negative Breast Cancer: Beyond Conventional TherapyDOI 10.20944/preprints202601.0915.v1
Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast CancerSemantic proximity
Triple-negative breast cancer: from none to multiple therapeutic targets in two decadesSemantic proximity
How shall we treat early triple-negative breast cancer (TNBC): from the current standard to upcoming immuno-molecular strategiesSemantic proximity
New Biomarkers and Treatment Advances in Triple-Negative Breast CancerSemantic proximity
Molecular targets and therapies associated with poor prognosis of triple‑negative breast cancer (Review)Semantic proximity
Divide and Conquer—Targeted Therapy for Triple-Negative Breast CancerSemantic proximity
Triple-negative breast cancer and the need for new therapeutic targets.Semantic proximity
Therapeutic Advances and New Directions for Triple-Negative Breast CancerSemantic proximity
Targeting Triple‐Negative Breast Cancer: Resistance Mechanisms and Therapeutic AdvancementsSemantic proximity
Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapiesSemantic proximity
Biology and Management of Patients With Triple-Negative Breast CancerSemantic proximity
Molecular pathways and therapeutic targets linked to triple-negative breast cancer (TNBC).Semantic proximity
Select a neighboring publication to make it the new centre.